Linezolid-Associated Neuropathy in Patients with MDR/XDR Tuberculosis in Shenzhen, China-Reference-Cited by-同舟云学术

Linezolid-Associated Neuropathy in Patients with MDR/XDR Tuberculosis in Shenzhen, China

Published:2022-05 Issue: Volume:Volume 15 Page:2617-2624
ISSN:1178-6973
Container-title:Infection and Drug Resistance
language:en
Short-container-title:IDR

Author:

Zhang Peize^ORCID,Li Wei^ORCID,Liu Miaona,Zhan Senlin,Zhang Hailin,Deng Guofang^ORCID,Chen Xiaoyou

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases,Pharmacology

Reference25 articles.

1. World Health Organization. Global Tuberculosis Report 2021. Geneva, Switzerland: World Health Organization; 2021.

2. Linezolid for drug-resistant pulmonary tuberculosis

3. World Health Organization. Rapid communication: key changes to treatment of multidrug- and rifampicin-resistant tuberculosis (MDR/RR-TB). Available from: http://www.who.int/tb/publications/2018/rapid_communications_MDR. Accessed May 13, 2022.

4. Efficacy and safety profile of linezolid in the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis: a systematic review and meta-analysis

5. Treatment of Highly Drug-Resistant Pulmonary Tuberculosis

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Linezolid in enterococcal urinary tract infection: a multicentre study;European Journal of Clinical Microbiology & Infectious Diseases;2024-08-21

2. A Transcriptomic Biomarker Predicting Linezolid-Associated Neuropathy During Treatment of Drug-Resistant Tuberculosis;Pathogens and Immunity;2024-06-25

3. Clinical research progress of novel antituberculosis drugs on multidrug-resistant tuberculosis;Postgraduate Medical Journal;2024-01-10

4. Treatment outcome, recurrence and safety of multidrug-resistant TB treated with low-dose linezolid;The International Journal of Tuberculosis and Lung Disease;2023-12-01

5. Occurrence and predictors of adverse events associated with Linezolid in the treatment of patients with MDR-TB;Pulmonology;2023-10